Bristol Myers Squibb Co. (BMY), And Talk Of Dividend Yields In Pharma
As the market continues to climb, investors are beginning to see thinning dividend yields on many of their big pharma shares.
Posts Tagged ‘Bristol Myers Squibb Co. (BMY)’
Merck & Co., Inc. (MRK): Post-Earnings Performance Questions
Merck & Co., Inc. (NYSE:MRK) stock could move up or down this week after the pharmaceutical company reports earnings on Wednesday.
How Will Merck & Co., Inc. (MRK)’s Earnings Fare Tomorrow?
Tomorrow, Merck & Co., Inc. (NYSE:MRK) will release its latest quarterly results.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY): A New Diabetes Duo Emerges
That's the message from today's announcement that Pfizer Inc. (NYSE:PFE) is out-licensing its diabetes drug candidate ertugliflozin to Merck & Co., Inc. (NYSE:MRK).
Merck & Co., Inc. (MRK): How This Can Eventually Lead To Healthy Returns
In the big pharma sector, it can oftentimes be hit or miss when seeking the next big growth stock.
Apple Inc. (AAPL), Novo Nordisk A/S (ADR) (NVO) & ‘The Most Sustainable Company in the World’
In January of 2012, Business Magazine released a list of the most sustainable companies in the world. You might be surprised to see who topped their list.
Pfizer Inc. (PFE), Bristol Myers Squibb Co. (BMY), and Alzheimer’s Milkshakes: The Growth of Medical Nutrition
A milkshake is not foremost on most people’s list of treatments for the neurological disorder Alzheimer’s.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK) & More: Drug Stocks on Citi’s Dividend Buy List
Barron's recently posted Citi's updated list of large, financially strong, high-yielding, dividend-paying companies.
Bristol Myers Squibb Co. (BMY): Growing Bigger and Better
Bristol Myers Squibb Co. (NYSE:BMY) has been in the spotlight for its so-called “desired” acquisitions and its size issues, along with patent expiration news.
ACADIA Pharmaceuticals Inc. (ACAD): FDA Throws This Stock a Juicy Bone
I had recommended staying away from the company for now because it looked too risky with a long wait before the company could complete its second phase 3 trial for pimavanserin...
Bristol Myers Squibb Co. (BMY): Is This Company Destined for Greatness?
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Johnson & Johnson (JNJ): This Company’s Biggest Drug Rivals
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Vical Incorporated (VICL), Bristol Myers Squibb Co. (BMY): This Biotech Stock Might Boost Your Portfolio
There are many promising biotech companies out there to choose from. One such company, named Vical Incorporated (NASDAQ:VICL), is targeting a cancer known as Melanoma.
AstraZeneca plc (AZN), Tesla Motors Inc (TSLA) & More: Three Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Bristol Myers Squibb Co. (BMY), Amgen, Inc. (AMGN): Tackling Cancer: Melanoma’s Biggest Current & Upcoming Players
As I noted five weeks ago, cancer statistics are both staggering and disappointing.
Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK): New Approved Treatment for Type 2 Diabetes Will Give JNJ a Sugar Rush
The drug, Invokana, the very first of its kind, was given the okay after nine clinical trials involving more than 10,000 patients with Type 2 diabetes.
Dendreon Corporation (DNDN), Bristol Myers Squibb Co. (BMY), Sanofi SA (ADR) (SNY), Vical Incorporated (VICL): Understanding Why Cancer Vaccines Fail
The immune system doesn't generally attack tumors on its own. Immune cells are designed to attack foreign invaders but leave the human cells alone.
Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY): This Pharma’s Dividend Is Safe for Now
Recently, with the loss of patents causing generic competition, the main attraction to pharmaceutical companies has been their dividend.
Should AstraZeneca plc (ADR) (AZN) and Bristol Myers Squibb Co. (BMY) Get Married?
It's been quite a while since we had a big wedding in the pharma world.
Amgen, Inc. (AMGN), Bristol Myers Squibb Co. (BMY): Is Merck & Co., Inc. (MRK)’s Type 2 Diabetes Blockbuster in Trouble?
For the last several years, Merck & Co., Inc.
Johnson & Johnson (JNJ), United Therapeutics Corporation (UTHR): 2 Can’t-Miss FDA Rulings Next Week
Normally, our weekly look at what's going on within the health-care sectors involves a mixture of health-care conferences, FDA panel meetings and decisions, and a plethora of ...
Orphan Drug Is Headed Back to Its Parent: NPS Pharmaceuticals, Inc. (NPSP), Eli Lilly & Co. (LLY)
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is bringing its kids home.
Johnson & Johnson (JNJ) Invokana PDUFA Preview: AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY)
It’s almost here! Johnson & Johnson (NYSE:JNJ) is eagerly awaiting a decision on its type 2 diabetes drug Invokana (canagliflozin) by the end of the month.
Is Bigger Better When it Comes to Big Pharma? Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY)
The demand for drugs worldwide is expected to increase due to emerging markets abroad and more specifically, due to an influx of demand from the aging "Baby Boomers" domestically...
Pfizer Inc. (PFE), Celgene Corporation (CELG): Tackling Cancer: Lung Cancer’s Biggest Current and Upcoming Players
As I noted three weeks ago, cancer statistics are both staggering and disappointing.
Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY): 3 Big Concerns for the Pharmaceutical Industry
It's not uncommon for me to applaud the pharmaceutical industry as a solid long-term investment.
Is Pfizer (PFE) Still a Big Pharma Kingpin?
Despite my recent obsession with Johnson & Johnson (NYSE:JNJ)'s restoration to health, I've long been a closet admirer of rival Pfizer Inc. (NYSE:PFE).
The Pipeline Power at Johnson & Johnson (JNJ): Bristol Myers Squibb Co. (BMY), GlaxoSmithKline plc (ADR) (GSK)
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Does Bristol Myers Squibb Co. (BMY)’s Dividend Have Room to Soar?
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into stocks to find yield.
Why Buffett Is Just Saying No to These Drug Majors: Bristol Myers Squibb Co. (BMY), Eli Lilly & Co. (LLY), AstraZeneca plc (ADR) (AZN)
Global pharmaceutical giants AstraZeneca plc (ADR) (NYSE:AZN), Bristol Myers Squibb Co. (NYSE:BMY), and Eli Lilly & Co. (NYSE:LLY) meet most of the growth and profitability...
Is Bristol-Myers Squibb Co. (BMY) One of the Best Companies in America?
The Motley Fool recently published its list of The 25 Best Companies in America and while Bristol-Myers Squibb Co.
Don’t Blame AbbVie Inc (ABBV) for Humira’s Success
Flip to the 2012 financial results for AbbVie Inc (NYSE:ABBV) and you'll see that its best-selling drug, Humira, brought in $9.27 billion in 2012, or 51% of the company's total...
Whoa! These 3 Stocks Easily Beat the Dow: Vical Incorporated (VICL), Diamond Foods, Inc. (DMND), Bristol Myers Squibb Co. (BMY)
Another day, another dollar, and another record high for the Dow Jones Industrial Average, which tacked on another 42-point gain yesterday, to bring the index to its highest levels...
There Is Potential in This Highly Lucrative Industry: Gilead Sciences, Inc. (GILD), Bristol Myers Squibb Co. (BMY), Johnson & Johnson (JNJ)
Gilead Sciences, Inc. (NASDAQ:GILD) is the world’s foremost biopharmaceutical company when it comes to combating deadly virus.
The Dow’s Best Health Care Stock: Merck & Co., Inc. (MRK)
Investing in the health care sector isn't easy.
Has Bristol Myers Squibb Co. (BMY) Become the Perfect Stock? – AstraZeneca plc (ADR) (AZN), Pfizer Inc. (PFE)
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
The FDA Gift That Keeps On Giving: Johnson & Johnson (JNJ), Bristol Myers Squibb Co. (BMY)
Eight months ago, Bayer and Johnson & Johnson (NYSE:JNJ) announced that the Food and Drug Administration had issued a complete response letter for their anticoagulant, Xarelto...
The Dow’s Best Health Care Stock: Pfizer Inc. (PFE)
Investing in the health care sector isn't easy.
The Perfect Cure for Hepatitis C? – Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ)
Gilead Sciences, Inc. (NASDAQ:GILD)' sofosbuvir with Johnson & Johnson (NYSE:JNJ) and Medivir's simeprevir are a match made in heaven.
Thinking Smaller Is Big for Big Pharma: Eli Lilly & Co. (LLY), Sanofi SA (ADR) (SNY), Bristol Myers Squibb Co. (BMY)
Do good things come in small packages for big pharma? Most of investors' attention is given to blockbuster drugs and drugs that have the potential to be blockbusters.
Last Week’s Big Dow Losers: Merck & Co., Inc. (MRK), United Technologies Corporation (UTX), Alcoa Inc (AA)
If you don't religiously follow the markets and are just seeing the weekly results for the first time, it would appear that this past week was simply a slight winner and nothing...
Who’s the Frailest Big Pharma of All? – Bristol Myers Squibb Co. (BMY), Pfizer Inc. (PFE), Sanofi SA (ADR) (SNY)
Mirror, mirror, on the wall, who's the frailest big pharma of all? The patent cliff has certainly taken its toll over the past couple of years, weakening several successful pharmaceutical...
Battle of the Pharma Dividends: Bristol Myers Squibb Co. (BMY) vs. Eli Lilly & Co. (LLY)
Are Bristol Myers Squibb Co. (NYSE:BMY) and Eli Lilly & Co.
Novo Nordisk A/S (ADR) (NVO): Still a Buy, Despite the Tresiba Setback
Shares of Novo Nordisk A/S (NYSE:NVO) are trying to recover from a recent sell-off that occurred after the FDA rejected its new drug Tresiba -- citing lack of a pre-approval ...
Merck & Co., Inc. (MRK): A Global Health Care Giant Doling Out a Massive Dividend
A SWOT analysis is a look at a company’s strengths, weaknesses, opportunities, and threats, and is a tremendous way to gain a detailed and thorough perspective on a company ...
Hepatitis C In Play for 2013?: Idenix Pharmaceuticals, Inc. (IDIX)
In the world of biotech stocks a lot of companies are starting to incorporate Hepatitis C treatments into their pipelines.
Pfizer Inc. (PFE): A Global Biotechnology Company in its 164th Year
A SWOT analysis is a look at a company’s strengths, weaknesses, opportunities, and threats, and is a great way to gain a detailed and thorough perspective on a company and its...
Sanofi SA (ADR) (SNY)’s GLP-1 Accepted for Review by FDA
Sanofi SA (ADR) (NYSE:SNY) announced this week that the Food and Drug Administration began to review the company's once-daily type 2 diabetes injectable lixisenatide.
This Is One Incredible CEO: Vertex Pharmaceuticals Incorporated (VRTX)
The Motley Fool's readers have spoken, and I have heeded your cries.
